Regener-Eyes Files Chapter 11 After FDA Warning Letter and Product Recall
Regener-Eyes LLC, the Palm Harbor FL biologic eye drops manufacturer, filed chapter 11 with $10-50 million in assets and liabilities. The FDA had issued a warning letter in August 2024 citing eight manufacturing violations, and the company initiated a voluntary product recall in December 2024.